CVS · 8-K · 20260805PR000097

Retail Pharmacy Pricing Pressure

CVS HEALTH Corp · 2026-08-05 · Importance 49 · Surprise 32

Pharmacy & Consumer Wellness revenue increased only 0.7% year over year to $33.8 billion despite a 4.3% increase in prescriptions filled. Regulatory-related price reductions on certain drugs, recent generic introductions and pharmacy reimbursement pressure largely offset drug-mix, volume and brand-inflation benefits. The company also cited consumer dynamics as a partial offset to operating performance. Same-store prescription volume increased 7.0%, while front-store same-store sales increased 1.0%, indicating stronger pharmacy than front-store demand.

Key facts

• Pharmacy & Consumer Wellness total revenues increase was primarily driven by pharmacy drug mix, increased prescription volume including contributions from Rite Aid asset acquisitions completed during Q3 2025, and brand inflation, largely offset by regulatory-related price reductions, recent generic introductions and pharmacy reimbursement pressure source